Geneos Wealth Management’s Invesco BulletShares 2031 Corporate Bond ETF BSCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.97M Buy
251,863
+212,013
+532% +$3.43M 0.07% 276
2026
Q2
$653K Buy
39,850
+818
+2% +$13.5K 0.01% 650
2026
Q1
$642K Buy
39,032
+3,591
+10% +$59.8K 0.01% 618
2025
Q4
$592K Buy
35,441
+194
+0.6% +$3.24K 0.01% 621
2025
Q3
$588K Buy
35,247
+504
+1% +$8.36K 0.01% 606
2025
Q2
$574K Buy
34,743
+11,992
+53% +$195K 0.01% 669
2025
Q1
$371K Buy
22,751
+6,945
+44% +$112K 0.01% 721
2024
Q4
$254K Buy
15,806
+5,249
+50% +$85.5K 0.01% 763
2024
Q3
$176K Buy
+10,557
New +$173K 0.01% 805

Other funds holding BSCV

Geneos Wealth Management's BSCV Position: Q3 2026 in Review

Geneos Wealth Management increased its Invesco BulletShares 2031 Corporate Bond ETF (BSCV) stake by 532% in Q3 2026, buying an estimated $3.43M and bringing the position to 251,863 shares worth $3.97M. The position accounts for 0.07% of the portfolio, ranked #276.

Geneos Wealth Management first reported a position in BSCV in Q3 2024 and has held it in 9 quarters since. 244 funds tracked by Wall St. Rank hold BSCV as of Q3 2026.

  • Geneos Wealth Management held 251,863 shares of Invesco BulletShares 2031 Corporate Bond ETF worth $3.97M as of Q3 2026.
  • Geneos Wealth Management bought 212,013 Invesco BulletShares 2031 Corporate Bond ETF shares in Q3 2026, an estimated $3.43M.
  • Invesco BulletShares 2031 Corporate Bond ETF made up 0.07% of Geneos Wealth Management's portfolio in Q3 2026, its #276 holding.
  • Geneos Wealth Management first reported a position in Invesco BulletShares 2031 Corporate Bond ETF in Q3 2024 and has held it in 9 quarters since.
  • 244 funds tracked by Wall St. Rank held Invesco BulletShares 2031 Corporate Bond ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.